BIIB: Biogen Inc
BIIB exchange rate has changed by 1.61% for today. During the day, the instrument was traded at a low of 198.59 and at a high of 203.70.
Follow Biogen Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BIIB News
- Biogen Stock And The Limitation Of The Tau Approach To Alzheimer's Disease (NASDAQ:BIIB)
- S&P 500 Top Stock Gainers Today, 7/20/26 - TipRanks.com
- Stoke Therapeutics: Its Dravet Syndrome Lead Asset Enters The Last Stretch (NASDAQ:STOK)
- Will AbbVie's Neuroscience Franchise Deliver Another Strong Quarter?
- Will Recent Setbacks Impact Growth Prospects of DNLI Stock?
- Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
- Tau In The Clinic, Again
- Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 - Slideshow (NASDAQ:BIIB) 2026-07-14
- Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 Transcript
- Stocks Settle Higher on Tame Inflation News
- Biogen Wins FDA Approval for Subcutaneous Starter Dose of Leqembi
- Ionis Begins Dosing in Phase I/II Dravet Syndrome Study
- Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'
- Stocks Settle Lower as Chipmakers Routed and US-Iran Tensions Escalate
- Stocks Retreat on Chipmaker Weakness and US-Iran Standoff
- Stocks Fall on Weakness in Chipmakers and Renewed US-Iran Hostilities
- Biogen's Q2 2026 Earnings: What to Expect
- DNLI Stock Surges 59.4% Year to Date: Is There More Room for Growth?
- IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study
- Why Biogen (BIIB) is Poised to Beat Earnings Estimates Again
- Amgen or Biogen: Which Biotech Stock Appears Better Poised?
Frequently Asked Questions
What is BIIB stock price today?
Biogen Inc stock is priced at 203.16 today. It trades within 198.59 - 203.70, yesterday's close was 199.95, and trading volume reached 1446. The live price chart of BIIB shows these updates.
Does Biogen Inc stock pay dividends?
Biogen Inc is currently valued at 203.16. Dividend policy depends on the company, while investors also watch 57.55% and USD. View the chart live to track BIIB movements.
How to buy BIIB stock?
You can buy Biogen Inc shares at the current price of 203.16. Orders are usually placed near 203.16 or 203.46, while 1446 and 1.85% show market activity. Follow BIIB updates on the live chart today.
How to invest into BIIB stock?
Investing in Biogen Inc involves considering the yearly range 124.55 - 219.72 and current price 203.16. Many compare -5.62% and 13.31% before placing orders at 203.16 or 203.46. Explore the BIIB price chart live with daily changes.
What are Biogen Inc stock highest prices?
The highest price of Biogen Inc in the past year was 219.72. Within 124.55 - 219.72, the stock fluctuated notably, and comparing with 199.95 helps spot resistance levels. Track Biogen Inc performance using the live chart.
What are Biogen Inc stock lowest prices?
The lowest price of Biogen Inc (BIIB) over the year was 124.55. Comparing it with the current 203.16 and 124.55 - 219.72 shows potential long-term entry points. Watch BIIB moves on the chart live for more details.
When did BIIB stock split?
Biogen Inc has gone through stock splits historically. These changes are visible in , 199.95, and 57.55% after corporate actions.
- Previous Close
- 199.95
- Open
- 199.47
- Bid
- 203.16
- Ask
- 203.46
- Low
- 198.59
- High
- 203.70
- Volume
- 1.446 K
- Daily Change
- 1.61%
- Month Change
- -5.62%
- 6 Months Change
- 13.31%
- Year Change
- 57.55%
- Act
- Fcst
- 1.978 M
- Prev
- -1.692 M
- Act
- Fcst
- 0.992 M
- Prev
- 0.430 M
- Act
- Fcst
- Prev
- 4.927%